{"id":"W2917694209","doi":"10.1212/wnl.0000000000007099","title":"Imaging outcome measures of neuroprotection and repair in MS","year":2019,"lang":"en","type":"review","venue":"Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University; St. Michael's Hospital","funders":"EMD Serono; Alberta Innovates; Multiple Sclerosis Society; National Institute of Neurological Disorders and Stroke; British Heart Foundation; Multiple Sclerosis Society of Canada; Genentech; National Multiple Sclerosis Society; International Progressive MS Alliance; Acorda Therapeutics; Vertex Pharmaceuticals; Conrad N. Hilton Foundation; Wellcome Trust; Fondation Brain Canada; F. Hoffmann-La Roche; Pfizer; Biogen; Celgene; National Institutes of Health; Canadian Institutes of Health Research; Guthy-Jackson Charitable Foundation; Disarm Therapeutics; U.S. Department of Defense; Sanofi; Chugai Pharmaceutical; MedDay Pharmaceuticals; GlaxoSmithKline; Medical Research Council; Teva Pharmaceutical Industries","keywords":"Neuroprotection; Multiple sclerosis; Medicine; Clinical trial; Neuroscience; Intensive care medicine; Medical physics; Psychology; Pathology; Psychiatry","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000429022,0.0002241432,0.00173855,0.0004629774,0.00002018324,0.000002800794,0.00008466302,0.0001605269,0.00001466695],"category_scores_gemma":[0.00121844,0.0001695375,0.000237958,0.0002161133,0.0001561778,0.00002485143,0.0001873203,0.0008787694,0.00001627825],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002300182,"about_ca_system_score_gemma":0.00007108755,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000226829,"about_ca_topic_score_gemma":0.00004506547,"domain_scores_codex":[0.9980273,0.0004325461,0.0005772501,0.0004622143,0.0002311564,0.0002695448],"domain_scores_gemma":[0.9989622,0.0003348629,0.0001921066,0.0003912292,0.00006682106,0.00005273654],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001265232,0.00005295814,0.02634063,0.02735265,0.00007761631,0.0001023882,0.00002411835,5.38965e-7,0.00004286613,0.000006280049,0.0001856887,0.9456878],"study_design_scores_gemma":[0.0006096734,0.0005390871,0.05650057,0.001156205,0.0002256471,0.0002194994,0.00000103104,0.00006879679,0.000001004017,0.000002901223,0.9405664,0.0001091621],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001195144,0.9963775,0.000003173298,0.0003547926,0.0002287804,0.001347066,0.00001068135,0.00005070429,0.0004321135],"genre_scores_gemma":[0.001135187,0.9983755,0.00002745431,0.0001991655,0.00007849056,0.00008151723,0.000004185419,0.00003874652,0.00005975299],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9455786,"threshold_uncertainty_score":0.691354,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2222122808611309,"score_gpt":0.4102756146866369,"score_spread":0.188063333825506,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}